BBLG Q2 2022 Earnings — Bone Biologics Corporation Revenue & Financial Results | Market Cap Arena

BBLGBone Biologics Corporation

$2M

Q2 2022 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$0

Gross Profit

$0

Operating Income

-$469,304

Net Income

-$469,304

EPS (Diluted)

$-10.88

QoQ Revenue Growth

NaN%

Cash Flow

Operating Cash Flow

-$360,064

Free Cash Flow

-$360,064

Stock-Based Comp.

$18,748

Balance Sheet

Total Assets

$6M

Total Liabilities

$70,636

Stockholders' Equity

$6M

Cash & Equivalents

$5M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	$0	$0	—
Operating Income	-$469,304	-$231,881	-102.4%
Net Income	-$469,304	-$491,898	+4.6%